AzcE | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

309 results for “AzcE”

Trials

View all 253 →

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

75 participants · First posted Oct 29, 2019

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

210 participants · First posted Sep 19, 2024

High Dose Ace Inhibitor Therapy Versus Combination of ACE and ARB Therapy

30 participants · First posted Sep 21, 2005

Drugs

View all 42 →

ADCE-003

ADCE-D01

ADCE-010

Organizations

AACE Pharmaceuticals Inc

United States

ACE Running LLC

United States

ACE VISION GROUP INC.

United States

News

Scientists Map the Enzymatic Route That Builds 5-Azacytidine in Nature, Revealing a Rare Skeletal-Editing Reaction

FDA Grants Fast Track Designation to Adcendo's ADCE-D01 for Soft Tissue Sarcoma Treatment

Adcendo's ADCE-D01 Receives FDA Clearance for Phase I/II Soft Tissue Sarcoma Trial

Page 1 of 31